|
Mobility and Mortality |
10/09/2020 - 8:30am to 9:30am EDT |
|
The Theory of Everything... Of Multiple Myeloma |
10/16/2020 - 8:20am to 9:30am EDT |
|
Blocking BCR Signaling and Beyond Chronic Lymphocytic Leukemia Today |
10/23/2020 - 8:30am to 9:30am EDT |
|
Development of BCR Pathway Inhibitors in CLL |
10/30/2020 - 8:30am to 9:30am EDT |
|
GVHD Studies From Specific to Broad Insights |
11/06/2020 - 8:30am to 9:30am EST |
|
Leveraging Premalignant Immunosurveillance to Prevent Myeloma Relapse |
11/13/2020 - 8:30am to 9:30am EST |
|
Targeting CD123 in AML: A Phase II Trial of Tagraxofusp +/- AZA in Newly Diagnosed sAML After Prior HMA |
11/20/2020 - 8:30am to 9:30am EST |
|
Hematologic Malignancies Grand Rounds 2020 |
11/27/2020 - 9:15am to 10:15am EST |
|
Hematologic Malignancies Grand Rounds 2020 |
12/04/2020 - 9:15am to 10:15am EST |
|
ASH2020 Multiple myeloma abstracts: bispecific antibody and CAR-T |
12/11/2020 - 8:30am to 9:30am EST |
Facebook
X
LinkedIn
Forward